89BIO INC's ticker is ETNB and the CUSIP is 282559103. A total of 71 filers reported holding 89BIO INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,981,719 | -10.4% | 1,293,988 | +9.9% | 0.00% | -33.3% |
| Q2 2023 | $22,303,947 | +190.6% | 1,176,989 | +133.6% | 0.00% | +200.0% |
| Q1 2023 | $7,675,087 | +175250.4% | 503,945 | +46.6% | 0.00% | 0.0% |
| Q4 2022 | $4,377 | -99.7% | 343,856 | +42.3% | 0.00% | – |
| Q3 2022 | $1,399,000 | +377.5% | 241,708 | +165.5% | 0.00% | – |
| Q2 2022 | $293,000 | -53.7% | 91,045 | -45.8% | 0.00% | – |
| Q1 2022 | $633,000 | -70.6% | 167,942 | +1.8% | 0.00% | – |
| Q4 2021 | $2,156,000 | -38.3% | 165,001 | -7.5% | 0.00% | – |
| Q3 2021 | $3,493,000 | +18.8% | 178,325 | +13.4% | 0.00% | – |
| Q2 2021 | $2,940,000 | -13.2% | 157,268 | +9.9% | 0.00% | -100.0% |
| Q1 2021 | $3,387,000 | +11.8% | 143,064 | +15.1% | 0.00% | 0.0% |
| Q4 2020 | $3,029,000 | +20.3% | 124,325 | +26.7% | 0.00% | – |
| Q3 2020 | $2,517,000 | +78.0% | 98,091 | +38.2% | 0.00% | – |
| Q2 2020 | $1,414,000 | -18.8% | 70,954 | +2.8% | 0.00% | – |
| Q1 2020 | $1,742,000 | -40.9% | 69,002 | -38.4% | 0.00% | – |
| Q4 2019 | $2,946,000 | – | 112,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orchard Capital Management, LLC | 551,879 | $7,025,420 | 2.36% |
| RA Capital Management | 8,955,410 | $114,002,369 | 2.31% |
| Cormorant Asset Management, LP | 2,550,000 | $32,462 | 2.17% |
| Deep Track Capital, LP | 3,850,000 | $49,010,500 | 2.06% |
| COMMODORE CAPITAL LP | 758,244 | $9,652 | 1.46% |
| Ikarian Capital, LLC | 454,000 | $5,779,419 | 1.39% |
| DAFNA Capital Management LLC | 324,173 | $4,126,722 | 1.16% |
| Parkman Healthcare Partners LLC | 332,880 | $4,237,562 | 1.13% |
| Boxer Capital, LLC | 1,400,000 | $17,822,000 | 0.94% |
| Orbimed Advisors | 3,658,869 | $46,577,402 | 0.89% |